In addition, overexpression of Src in association with reduced expression of a negative regulator of Src, the C-terminal Src kinase, has been observed [61, 62] and activation of the Src family of tyrosine kinases has been linked to adherens junction disassembly, increased β-catenin-signalling and cancer progression [63, 64]. The gene discussed is SRC; the disease is cancer.